2018-04-17 08:30
The study, presented at the ongoing AACR congress in Chicago, concluded that using DiviTum to measure cell proliferation in blood samples could potentially be used to assess cell cycle modulation by Ibrance®. “We are pleased that DiviTum is...
2018-03-28 08:00
The study, consisting of 31 patients with metastatic breast cancer, was performed at the Prato Hospital, Italy. The results are published in the scientific journal Oncotarget and demonstrates that DiviTum can evaluate efficacy of standard hormonal therapy...
2018-03-20 08:00
The value of the order is approximately 100 000 USD. "New and more effective cancer treatment are important in order to improve patient outcome. At the same time, it’s expensive to develop new cancer drugs. With DiviTum, we aim to provide value...
2018-02-22 11:53
100 women with metastasized breast cancer will be included in the study, with the objective to find markers to identify early development of resistance of today's standard treatment in combination with Ibrance®. By early identification of women...
2017-12-05 08:30
Adam has experience in production management and process development. He has worked, among other things, to develop and implement new production methods in ISO13485-certified medical technology companies. Adams previous professional experiences include...
2017-11-23 08:00
Led by Dr Cynthia Ma, the study investigated 50 women with breast cancer treated with standard endocrine therapy in combination with Ibrance® prior to surgery. DiviTum® was used to measure cell proliferation rate in blood samples collected before...
2017-11-21 08:00
The proof of concept study, including 404 patients, provides evidence for using DiviTum as a dynamic biomarker before and during therapy to give important answers regarding prognosis and how effective therapy is. Biovica’s assay was prognostic for...
2017-11-14 08:00
With imaging methods used for evaluating the effect of treatment, it takes about three months to evaluate whether the given therapy is effective or not. The new study demonstrates that DiviTum® accurately can predict outcome (progression free- and...
2017-11-08 09:00
At the conference Mattias will address how novel ways to measure cell proliferation offers new solutions to old challenges in drug development. Enhanced evaluation of drug efficacy by new assays such as DiviTum® can save development time and cost...
2017-11-06 09:00
For more information follow the link https://www.facebook.com/groups/smabolagsjakten/ During the live QA session, you will be given the opportunity to ask questions directly to the company management in Swedish or English. Answers will then be given in...

>4,500

Numbers of patients in studies

28

Publications

22

Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program

No